[1]王刚,周敬群. β-NGF减轻H2O2对HUVECs的损伤 [J]. 基础医学与临床, 2015, 35:228-230. [2]Gimbrone MA, García-Cardeña G. Endothelial cell dysfunction and the pathobiology of atherosclerosis [J]. Circ Res, 2016, 118:620-636. [3]Steven S, Munzel T, Daiber A. Exploiting the pleiotropic antioxidant effects of established drugs in cardiovascular disease [J]. Int J Mol Sci, 2015, 16:18185-18223. [4]Ding Y, Gu Z, Zhai T, et al. Effect of butylphthalide on new cerebral microbleeds in patients with acute ischemic stroke [J]. Medicine (Baltimore), 2020, 99:e21594. doi: 10.1097/MD.0000000000021594. [5]刘雅林, 谢兰兰, 王丽云, 等. 丁苯酞减轻阿尔茨海默病大鼠海马神经元凋亡 [J]. 基础医学与临床, 2019, 39:1746-1751. [6]Santos-Parker JR, Strahler TR, Bassett CJ, et al. Curcumin supplementation improves vascular endothelial func-tion in healthy middle-aged and older adults by increasing nitric oxide bioavailability and reducing oxidative stress [J]. Aging (Albany NY), 2017, 9:187-208. [7]Daiber A, Steven S, Weber A, et al. Targeting vascular (endothelial) dysfunction [J]. Br J Pharmacol, 2017, 174:1591-1619. [8]Marchi S, Patergnani S, Missiroli S, et al. Mitochondrial and endoplasmic reticulum calcium homeostasis and cell death [J]. Cell Calcium, 2018, 69:62-72. [9]Cui LY, Zhu YC, Gao S, et al. Ninety-day administration of dl-3-n-butylphthalide for acute ischemic stroke: a randomized, double-blind trial [J]. Chin Med J (Engl), 2013, 126:3405-3410. [10]Li Z, Lu J, Ma L, et al. DL-3-n-butylphthalide for alleviation of neurological deficit after combined extracranial-intracranial revascularization for moyamoya disease: a propensity score-matched analysis [J]. J Neurosurg, 2019, 132:421-433. [11]殷建瑞, 张波, 谭丽华, 等. 丁苯酞对缺氧缺糖条件下血管内皮细胞VEGF和HIF-1α表达的影响 [J]. 中国病理生理学杂志, 2011, 27:643-647. [12]Chen W, Yang J, Chen S, et al. Importance of mitochondrial calcium uniporter in high glucose-induced endothelial cell dysfunction [J]. Diab Vasc Dis Res, 2017, 14:494-501. |